Angiogenesis
During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
- B1408 CNX-774Summary: BTK inhibitor, orally active, irreversible and selective
- A8164 Cyclo (-RGDfK)3 CitationSummary: Inhibitor of αvβ3 integrin
- A3206 AVL-292Summary: Btk inhibitor
- A3302 CGI-17461 CitationTarget: BTKSummary: Btk inhibitor
- A3415 Firategrast1 CitationSummary: α4β1/α4β7 integrin antagonist
- B5492 TCS 2314Summary: integrin very late antigen-4 (VLA-4; α4β1) antagonist
- B5631 TC-I 15Summary: α2β1 integrin inhibitor
- B5770 Leukadherin 1Summary: CD11b/CD18 activator
- B4862 CWHM-12Summary: inhibitor of αV integrins
- B5851 FG2216Target: Pyruvate dehydrogenases (PDH)Summary: HIF-prolyl hydroxylase inhibitor